Zofran Birth Defect Defendant Files FDA Citizen Petition As Part Of Preemption Bid
BOSTON — GlaxoSmithKline LLC (GSK) on Nov. 1 filed a citizen petition asking the Food and Drug Administration for an opinion about Zofran’s birth defect warnings, a move that plaintiffs in...To view the full article, register now.
Already a subscriber? Click here to view full article